Global Urinary Incontinence Treatment Devices Market Size By Product (Urethral slings, Electrical Stimulation Devices, Artificial Urinary Sphincters), By Incontinence-Type (Stress Urinary Incontinence, Urge Urinary Incontinence), By End-User (Hospitals, Ambulatory Surgery Centers, Clinics), By Geographic Scope And Forecast

Urinary Incontinence Treatment Devices Market Size And Forecast

Urinary Incontinence Treatment Devices Market size was valued at USD 2,860.63 Million in 2022 and is projected to reach USD 5222.44 Million by 2030 growing at a CAGR of 8.1% from 2023 to 2030.

In the upcoming years, it is anticipated that the market would grow as a result of rising chronic conditions including kidney stones and patients’ propensity to undergo surgery to treat urine incontinence. The increased incidence of urinary incontinence is the main element driving the market’s expansion. The Global Urinary Incontinence Treatment Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Urinary Incontinence Treatment Devices Market Definition

The involuntary passing of urine as a result of a loss of bladder control is known as urinary incontinence. Urinary incontinence affects millions of individuals worldwide, and women are more likely to experience it than males. The lack of the ability to contain pee causes urinary incontinence, which is uncontrolled urine loss. It is a condition in which the body is unable to manage the bladder. Urinary incontinence can affect both men and women, but women are more likely to have it. Menopause, childbirth, urinary tract infections, and weakness of the pelvic muscles are among the causes of incontinence.

Urinary incontinence originates in a variety of forms, including urge, overflow, stress, mixed, functional, psychogenic, and incontinence due to other conditions. The patients are treated with urinary incontinence treatment devices that either change the posture of the bladder or block the flow of pee. Urinary incontinence significantly affects one’s emotional, psychological, and social well-being; the majority of people who experience it are unable to complete daily tasks with assurance. This encourages the creation of efficient treatments for the problem.

Global Urinary Incontinence Treatment Devices Market Overview

In the anticipated period, the market is anticipated to be driven by an increase in the prevalence of overactive bladder in the geriatric population. A rise in demand for minimally invasive procedures could fuel industry expansion. In the upcoming years, it is anticipated that the market would grow as a result of rising chronic conditions including kidney stones and patients’ propensity to undergo surgery to treat urine incontinence. The increased incidence of urinary incontinence is the main element driving the market’s expansion. The symptoms of urine incontinence can occur for a variety of reasons, including urinary tract infections, weakened pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and after radical prostatectomy surgery in males.

Other factors contributing to the significant market growth include the creation of novel urological incontinence devices, an ageing population with a higher risk of urological conditions, and a rise in the number of patients with urinary incontinence switching from non-surgical options to cutting-edge surgical procedures. Market expansion is limited to some extent by factors including post-operative difficulties linked to the devices and lack of awareness of new breakthroughs in urinary incontinence devices. Additionally, the rise in healthcare costs in developing nations presents profitable investment prospects for the market’s competitors. However, a lack of consumer knowledge about urinary incontinence treatments could constrain the market.

Global Urinary Incontinence Treatment Devices Market Segmentation Analysis

The Global Urinary Incontinence Treatment Devices Market is segmented on the basis of Product, Incontinence-Type, End-User, And Geography.

Urinary Incontinence Treatment Devices Market, By Product

• Urethral slings
• Electrical Stimulation Devices
• Artificial Urinary Sphincters
• Catheters

Based on Product, the market is segmented into Urethral slings, Electrical Stimulation Devices, Artificial Urinary Sphincters, and Catheters. In 2022, the urethral slings segment was dominated by the female slings sub-segment. From 2023 to 2030, the sub-segment is anticipated to increase its market share. The high market share of the catheter segment is attributable to the widespread use of Foley catheters and intermittent catheters for bladder emptying, as well as to technologically sophisticated goods to prevent infection and the simplicity of intermittent catheters.

Urinary Incontinence Treatment Devices Market, By Incontinence-Type

• Stress Urinary Incontinence
• Urge Urinary Incontinence
• Mixed Incontinence
• Overflow Incontinence

Based on Incontinence-Type, the market is segmented into Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, and Overflow Incontinence. The market segment with the largest revenue in 2022, accounting for almost half of the overall market share, is predicted to continue in this direction throughout the duration of the forecast. Stress urine incontinence is brought on by the stretching and weakening of a woman’s pelvic floor muscles during pregnancy and childbirth. Stress urine incontinence can potentially be a side effect of prostate surgery in men. Stress urine incontinence is now the most common condition in both men and women due to this.

Urinary Incontinence Treatment Devices Market, By End-User

• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Home Use

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centers, Clinics, and Home Use. In 2022, the hospital sector held a significant portion of the global market, followed by the ambulatory surgery sector. The expansion of the hospitals and ambulatory surgery centers segments is anticipated to be aided by the rise in the number of multinational hospitals using modern sling surgery techniques like TVT & TOT and the adoption of tiny slings.

Urinary Incontinence Treatment Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Urinary Incontinence Treatment Devices Market is classified into North America, Europe, Asia Pacific, and Rest of the world. During the course of the forecast period, North America is anticipated to dominate the market for urinary incontinence treatment devices. The presence of a larger patient pool and an expanding senior population is primarily responsible for the highest share. Other factors driving the market in this region include the presence of excellent healthcare infrastructure and well-established insurance policies. Due to reasons including the rising senior populations and the country’s expanding patient pools, the United States has the greatest market share in the North American area.

Throughout the projected period, the market for urinary incontinence devices is anticipated to develop at the fastest rate in Asia-Pacific. Due to its large population, rising disposable incomes, and increasing patient knowledge of cutting-edge urinary incontinence management, Asia-Pacific poses an attractive potential for market participants who specialize in urinary incontinence devices. In Asia-Pacific, Japan, India, and China are among the nations with the highest rates of urine incontinence, which further supports the region’s strong performance on the worldwide market.

Key Players

The “Global Urinary Incontinence Treatment Devices Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson, and Company), Coloplast Group, Promedon Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), ZSI Surgical Implants S.R.L., InControl Medical LLC, Hollister Incorporated, and Atlantic Therapeutics Group Ltd.

Our market analysis includes a section specifically devoted to such major players, where our analysts give an overview of each player’s financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned players globally are also included in the competitive landscape section.

Key Developments

• In June 2023, Axena Health, Inc., a FemTech medical device company focused on scalable treatments for female pelvic health, introduced the Leva Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI), also called accidental bowel leakage (ABL), in women. The U.S. Food and Drug Administration (FDA) cleared the new indication in 2022 following Breakthrough Device Designation in 2021. New coaching and education support along with updates to the Leva System app combine to support its use for chronic FI, making access to first-line treatment easy and practical.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Urinary Incontinence Treatment Devices Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Urinary Incontinence Treatment Devices Market, gauge the attractiveness of a certain sector, and assess investment possibilities.